# Targeted Lung Denervation for Patients With Moderate to Severe COPD

> **NCT02058459** · NA · COMPLETED · sponsor: **Nuvaira, Inc.** · enrollment: 128 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DEVICE:** Holaira™ Lung Denervation System with energy delivery
- **DEVICE:** Holaira™ Lung Denervation System without energy delivery

## Key facts

- **NCT ID:** NCT02058459
- **Lead sponsor:** Nuvaira, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-04
- **Primary completion:** 2018-01-26
- **Final completion:** 2020-06-16
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2022-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02058459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02058459, "Targeted Lung Denervation for Patients With Moderate to Severe COPD". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02058459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*